<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34462376</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1881-6096</ISSN><JournalIssue CitedMedium="Print"><Volume>73</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Brain and nerve = Shinkei kenkyu no shinpo</Title><ISOAbbreviation>Brain Nerve</ISOAbbreviation></Journal><ArticleTitle>[Differentiating Between HTLV-1 Associated Myelopathy and Amyotrophic Lateral Sclerosis: A Case Report].</ArticleTitle><Pagination><StartPage>1037</StartPage><EndPage>1040</EndPage><MedlinePgn>1037-1040</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11477/mf.1416201884</ELocationID><Abstract><AbstractText>We present the case of a 72-year-old woman with slowly progressive spastic paraplegia and painful muscle spasms of the lower limbs. Spastic paraplegia began in the left lower extremity and extended to the right lower extremity 4 months later. We considered the diagnosis of amyotrophic lateral sclerosis (ALS) because of the left-dominant spastic paraplegia of bilateral lower limbs and due to the presence of fasciculation, hyperreflexias, and pathological reflexes. However, cerebrospinal fluid (CSF) examination revealed that cell count and protein values were increased. The patient also had an increased titer of anti-HTLV-1 antibodies in serum and CSF and was diagnosed with HTLV-1 associated myelopathy (HAM). She was treated with steroids, and her symptoms improved. Distinguishing HAM from ALS may be difficult because HAM may present with unilateral spastic paralysis and may be accompanied by fasciculation. Careful and accurate evaluation is necessitated to differentiate between these conditions for a conclusive diagnosis. (Received 1 March, 2021; Accepted 26 April, 2021; Published 1 September, 2021).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fuseya</LastName><ForeName>Kimiharu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Gifu University Graduate School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshikura</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Masahiko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Akio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Shimohata</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Brain Nerve</MedlineTA><NlmUniqueID>101299709</NlmUniqueID><ISSNLinking>1881-6096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015481">HTLV-I Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005207" MajorTopicYN="N">Fasciculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015481" MajorTopicYN="N">HTLV-I Antibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015368" MajorTopicYN="Y">Human T-lymphotropic virus 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015493" MajorTopicYN="Y">Paraparesis, Tropical Spastic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>5</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34462376</ArticleId><ArticleId IdType="doi">10.11477/mf.1416201884</ArticleId><ArticleId IdType="pii">1416201884</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>